Processa Pharmaceuticals Investor Relations Material

Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for patients with unmet medical needs. The company is engaged in the research and development of drug candidates aimed at addressing serious conditions across multiple therapeutic areas, including oncology and infectious diseases. Processa Pharmaceuticals' approach involves advancing its drug candidates through clinical trials to provide safer and more effective therapies. Its pipeline targets conditions where current treatment options may be limited or inadequate, aiming to improve patient outcomes and quality of life. The company is headquartered in Hanover, Maryland, and its shares are listed on the NASDAQ.